ATE512160T1 - T-cell-epitope aus dem unreifen lamininrezeptorprotein (oncofoetal antigen) und deren medizinische verwendungen - Google Patents

T-cell-epitope aus dem unreifen lamininrezeptorprotein (oncofoetal antigen) und deren medizinische verwendungen

Info

Publication number
ATE512160T1
ATE512160T1 AT05009095T AT05009095T ATE512160T1 AT E512160 T1 ATE512160 T1 AT E512160T1 AT 05009095 T AT05009095 T AT 05009095T AT 05009095 T AT05009095 T AT 05009095T AT E512160 T1 ATE512160 T1 AT E512160T1
Authority
AT
Austria
Prior art keywords
tumor
present
relates
laminin receptor
immature laminin
Prior art date
Application number
AT05009095T
Other languages
English (en)
Inventor
Matthias Zeis
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Application granted granted Critical
Publication of ATE512160T1 publication Critical patent/ATE512160T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05009095T 2005-04-26 2005-04-26 T-cell-epitope aus dem unreifen lamininrezeptorprotein (oncofoetal antigen) und deren medizinische verwendungen ATE512160T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05009095A EP1717245B1 (de) 2005-04-26 2005-04-26 T-cell-Epitope aus dem unreifen Lamininrezeptorprotein (Oncofoetal Antigen) und deren medizinische Verwendungen

Publications (1)

Publication Number Publication Date
ATE512160T1 true ATE512160T1 (de) 2011-06-15

Family

ID=34935739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05009095T ATE512160T1 (de) 2005-04-26 2005-04-26 T-cell-epitope aus dem unreifen lamininrezeptorprotein (oncofoetal antigen) und deren medizinische verwendungen

Country Status (14)

Country Link
US (1) US7968097B2 (de)
EP (2) EP1717245B1 (de)
JP (1) JP4870751B2 (de)
CN (1) CN101166759B (de)
AT (1) ATE512160T1 (de)
AU (1) AU2006239505B2 (de)
BR (1) BRPI0610841A2 (de)
CA (1) CA2606088C (de)
EA (1) EA013598B1 (de)
ES (1) ES2367643T3 (de)
NO (1) NO20076041L (de)
NZ (1) NZ563432A (de)
UA (1) UA97092C2 (de)
WO (1) WO2006114307A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004012681A2 (en) * 2002-08-02 2004-02-12 South Alabama Medical Sciences Foundation Cancer vaccines containing epitopes of oncofetal antigen
US20090004213A1 (en) * 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
CA2817054C (en) * 2007-07-27 2017-02-28 Immatics Biotechnologies Gmbh Composition of tumour-associated peptides and related anti-cancer vaccine
DK2113253T3 (da) * 2008-04-30 2010-07-19 Immatics Biotechnologies Gmbh Ny sammensætning af tumorassocierede peptider, der bindes til humant leukocyt-antigen (HLA) klasse I eller II molekyler, til vaccinebrug
CN102574925A (zh) * 2009-03-26 2012-07-11 昆腾免疫有限公司 用于诊断及临床应用的癌胚胎抗原/未成熟层粘连蛋白受体抗体
WO2011006084A2 (en) * 2009-07-09 2011-01-13 South Alabama Medical Science Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof
JPWO2011024791A1 (ja) * 2009-08-25 2013-01-31 タカラバイオ株式会社 レチノイン酸存在下でのｔ細胞集団の製造方法
EP2330122A1 (de) * 2009-12-02 2011-06-08 Asklepios Kliniken Hamburg Gmbh OFA/iLRP-abgeleitetes modifiziertes Peptid
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
EP4317432A3 (de) 2016-12-08 2024-04-17 Immatics Biotechnologies GmbH T-zell-rezeptoren mit verbesserter paarung
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
PE20191711A1 (es) * 2017-04-10 2019-11-28 Immatics Biotechnologies Gmbh Peptidos y combinaciones de los mismos para el uso en la inmunoterapia contra diversos tipos de cancer
WO2018224166A1 (en) * 2017-06-09 2018-12-13 Biontech Rna Pharmaceuticals Gmbh Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
EP3796923A4 (de) * 2018-05-18 2022-03-09 Children's National Medical Center Verbesserte gezielte t-zelltherapie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10506004A (ja) 1994-07-27 1998-06-16 ザ カウンシル オブ ザ クィーンズランド インスティテュート オブ メディカル リサーチ ポリエピトープワクチン
ES2203782T3 (es) 1996-01-17 2004-04-16 Imperial College Innovations Limited Inmunoterapia que utiliza linfocitos t citotoxicos (ctl).
US20040236091A1 (en) 2001-03-28 2004-11-25 Chicz Roman M. Translational profiling
WO2004012681A2 (en) 2002-08-02 2004-02-12 South Alabama Medical Sciences Foundation Cancer vaccines containing epitopes of oncofetal antigen
JP2006516089A (ja) 2002-10-02 2006-06-22 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
US20070166318A1 (en) * 2003-05-30 2007-07-19 Macina Roberto A Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
US20080206270A1 (en) * 2004-07-08 2008-08-28 Minev Boris R Enhancing Class I Antigen Presentation With Synthetic Sequences

Also Published As

Publication number Publication date
CA2606088C (en) 2015-05-26
WO2006114307A1 (en) 2006-11-02
US7968097B2 (en) 2011-06-28
US20090041794A1 (en) 2009-02-12
NO20076041L (no) 2007-11-23
CN101166759A (zh) 2008-04-23
EP1874810A1 (de) 2008-01-09
JP2008538901A (ja) 2008-11-13
ES2367643T3 (es) 2011-11-07
EA200702202A1 (ru) 2008-04-28
UA97092C2 (ru) 2012-01-10
CA2606088A1 (en) 2006-11-02
JP4870751B2 (ja) 2012-02-08
EP1717245B1 (de) 2011-06-08
CN101166759B (zh) 2012-09-05
AU2006239505B2 (en) 2012-05-10
AU2006239505A1 (en) 2006-11-02
EP1717245A1 (de) 2006-11-02
BRPI0610841A2 (pt) 2010-07-27
EA013598B1 (ru) 2010-06-30
NZ563432A (en) 2010-11-26

Similar Documents

Publication Publication Date Title
NO20076041L (no) Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser derav
EA200800677A1 (ru) Опухолеассоциированные пептиды, беспорядочно связывающиеся с молекулами класса ii человеческого лейкоцитарного антигена (hla)
EA200800676A1 (ru) Опухолеассоциированные пептиды, связывающиеся с молекулами человеческого лейкоцитарного антигена (hla) i или ii класса, и относящаяся к ним противораковая вакцина

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties